Streamline Health Solutions
STRM
STRM was delisted on the 11th of August, 2025.
40 hedge funds and large institutions have $8.07M invested in Streamline Health Solutions in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 9 closing their positions.
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
0.04% more ownership
Funds ownership: 2.08% → 2.12% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 45 → 40 (-5)
54% less capital invested
Capital invested by funds: $17.4M → $8.07M (-$9.33M)
56% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$214K |
| 2 |
AWM
Austin Wealth Management
Austin,
Texas
|
+$199K |
| 3 |
Cerity Partners
New York
|
+$127K |
| 4 |
MFIM
Mesirow Financial Investment Management
Chicago,
Illinois
|
+$52.6K |
| 5 |
NHC
Nicholas Hoffman & Company
Atlanta,
Georgia
|
+$31K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$194K |
| 2 |
BFM
Boothbay Fund Management
New York
|
-$159K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$114K |
| 4 |
PAIM
Punch & Associates Investment Management
Edina,
Minnesota
|
-$103K |
| 5 |
TC
TownSquare Capital
Provo,
Utah
|
-$54.2K |
STRM Hedge Fund Activity: Q4 2023 in Review
40 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Streamline Health Solutions (STRM) for Q4 2023, worth a combined $8.07M — down 54% from $17.4M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of STRM and 4 opened new positions — a net loss of 5 holders — while 11 trimmed existing stakes and 12 added.
The largest buyer was Perkins Capital Management, adding an estimated $214K. The largest seller was UBS Group, cutting an estimated $194K.
- 40 institutional investors held Streamline Health Solutions (STRM) as of Q4 2023, down from 45 in Q3 2023.
- Funds reported $8.07M of Streamline Health Solutions stock for Q4 2023, down 54% quarter-over-quarter.
- 4 funds opened new Streamline Health Solutions positions in Q4 2023 and 9 closed out, a net change of -5 holders.
- The largest Streamline Health Solutions buyer in Q4 2023 was Perkins Capital Management, an estimated $214K added.
- The largest Streamline Health Solutions seller in Q4 2023 was UBS Group, an estimated $194K sold.
Based on aggregated 13F filings for Q4 2023.